Autres langues Quantum Genomics

Actions

ALQGC

FR0011648971

Marché Fermé - Euronext Paris Autres places de cotation 16:16:53 19/04/2024			Varia. 5j.	Varia. 1 janv.
0,1176 ^EUR	+2,26 %		+4,26 %	+10,94 %

14/03	Stop ou encore ?
14/03	Assystem : Engie, Saint-Gobain, Technip Energies... les valeurs à suivre aujourd'hui à la Bourse de Paris	AO

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Bolsa de Madrid: ¿Parar o continuar?	14/03
Quantum Genomics : Quantum Genomics publishes its results for the 2023 financial year. The merger with ExactCure, which marks the strategic redeployment of the company and will be submiCed for a shareholder vote on April 24.	13/03
Quantum Genomics Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2023	13/03
Bolsa de Madrid: Christine estropea un poco la fiesta de Jerome	15/12
Quantum Genomics : Quantum Genomics enters into exclusive negotiations with ExactCure	14/12
Quantum Genomics : Quantum Genomics Releases First-Half 2023 Financial Results	24/10/23
Quantum Genomics Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	24/10/23
Quantum Genomics : Quantum Genomics announces resuming discussions with HealthTech companies following the termination of exclusive negotiations with Vistacare Medical	17/10/23
Quantum Genomics : Quantum Genomics enters into exclusive negotiations with Vistacare Medical with the ambition of creating a reference player in the management of complex wounds	20/07/23
Global markets live: Microsoft, Raytheon, JPMorgan, Credit Suisse...	26/05/23
Bolsa de Madrird: La tecnología en su burbuja	26/05/23
Quantum Genomics : Quantum Genomics releases its 2022 financial results and provides an update on its MandA discussions	26/05/23
Quantum Genomics Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2022	26/05/23
Bolsa de Madrid: Cuanto más tiempo pase, peor será	23/02/23
Quantum Genomics Ousts Board President; CEO Named Successor	23/02/23
Quantum Genomics : Quantum Genomics announces reorganization of its Board of Directors and staff restructuration in order to focus on new projects	22/02/23
Quantum Genomics : Quantum Genomics gives an update	08/12/22
Quantum Genomics' Hypertension Drug Firibastat Fails to Show Significant Efficacy in Late-Stage Trial	28/10/22
Quantum Genomics : Quantum Genomics announces lack of significant efficacy for firibastat in their phase III study, FRESH and is redirecting to new developments	28/10/22
Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments	28/10/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Quantum Genomics

Actions

ALQGC

FR0011648971

Autres langues

Filtres